Previous 10 | Next 10 |
2024-02-07 05:05:00 ET Summary Historically, InTest derived most of its revenues from the semiconductor capital equipment end market. The company is intentionally growing its business in other end markets to reduce cyclicality and provide a more stable base of cash flows to deploy...
Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development PR Newswire Danaher Beacon for Preclinical Drug Safety seeks to address major cause of failure in clinical trials Program will...
2024-02-03 05:17:20 ET Summary Danaher's annual results show a decrease in sales and EBIT due to the boost in sales of the COVID-19 pandemic. The company has made strategic acquisitions and spin-offs to improve its business segments and position itself for long-term growth. Da...
2024-02-01 08:15:02 ET Needham analyst issues OVERWEIGHT recommendation for DHR on February 1, 2024 07:48AM ET. The previous analyst recommendation was Overweight. DHR was trading at $239.91 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-01-30 13:06:07 ET Summary Despite recent challenges, Danaher remains resilient and strategically positioned for long-term success. Danaher's 4Q23 results, while showing declines, highlight strategic steps and acquisitions, setting the stage for sustained growth. Despite h...
2024-01-30 11:03:03 ET Danaher Corporation (DHR) Q4 2023 Earnings Conference Call January 30, 2024, 08:00 AM ET Company Participants John Bedford - VP of IR Rainer Blair - President and CEO Matt McGrew - EVP and CFO Conference Call Participants Dan Br...
2024-01-30 08:18:25 ET More on Danaher Danaher Corporation (DHR) 42nd Annual JPMorgan Healthcare Conference (Transcript) Danaher: Continuously Compounding My Top 2024 Stock Pick: Danaher Danaher beats top and bottom line estimates; initiates Q1 and FY24 soft ...
2024-01-30 06:03:46 ET More on Danaher Danaher: Continuously Compounding My Top 2024 Stock Pick: Danaher Danaher, Repligen rise as German peer Sartorius beats in Q4 Read the full article on Seeking Alpha For further details see: Danaher beats top ...
Hang Lung Properties Limited ADR (HLPPY) is expected to report for Q4 2023 Hope Bancorp Inc. (HOPE) is expected to report $0.28 for Q4 2023 Cambridge Bancorp (CATC) is expected to report $0.92 for Q4 2023 RenaissanceRe Holdings Ltd. (RNR) is expected to report $8.13 for Q4 2023 Po...
Danaher Reports Fourth Quarter and Full Year 2023 Results PR Newswire WASHINGTON , Jan. 30, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2023. All results in this release r...
News, Short Squeeze, Breakout and More Instantly...
Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis PR Newswire The Danaher Beacon for Brain Injury Diagnostics seeks to identify mild Traumatic Brain Injury (TBI) earlier and more precisely. Scientists will evaluate new bl...
Danaher to Present at Bank of America Securities Healthcare Conference PR Newswire WASHINGTON , May 7, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair , will be presenting at...
Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry PR Newswire WOBURN, Mass. , May 3, 2024 /PRNewswire/ -- Curiox Bi...